NCT04894981

Brief Summary

This study aims to assess the impact of the choice of visual feedback solution (immersive via CAVE and VR headset; non-immersive via screen only) on driving performance and quality of experience on a physical driving simulator and its acceptability to wheelchair drivers with neurological disorders.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 3, 2021

Completed
7 days until next milestone

Study Start

First participant enrolled

May 10, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 20, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 26, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 26, 2021

Completed
Last Updated

November 1, 2021

Status Verified

May 1, 2021

Enrollment Period

6 months

First QC Date

May 3, 2021

Last Update Submit

October 29, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • number of the collisions with the environment on the standardised circuit

    It will be compared in 4 conditions : * immersive 1: physical simulator and CAVE\_condition A1 * immersive 2: physical simulator and virtual reality helmet\_condition A2 * non-immersive 1: screen and physical simulator\_condition B1 * non-immersive 2: screen only without simulator\_condition B2 Day 1 : A + B Day 8 : A + B

    During the driving course, from the beginning to the end of the circuit.

Secondary Outcomes (8)

  • the time taken to complete the course

    During the driving course, from the beginning to the end of the circuit.

  • evaluation of driving performance with Wheelchair Skill Test (WST-Q-T 5.1)

    Immediately after intervention

  • visual information (VICON® system)

    During the driving course, from the beginning to the end of the circuit.

  • the cognitive load of carrying out the circuit with National Aeronautics and Space Administration Task Load Index

    Immediately after intervention

  • sensation of immersion and the feeling of presence in a virtual situation (Igroup Presence Questionnaire IPQ)

    Immediately after intervention

  • +3 more secondary outcomes

Study Arms (2)

Immersive condition

EXPERIMENTAL

Performance driving wheelchair in immersive condition (in Cave automatic environment or with HMD)

Device: Immersive condition (CAVE)Device: Immersive condition (HMD)

Non Immersive condition

EXPERIMENTAL

Performance driving wheelchair in non immersive condition (with screen and physical simulator or screen only)

Device: Non Immersive condition (Screen alone)Device: Non Immersive condition (Screen with physical simulator)

Interventions

Driving course with obstacles in a CAVE system

Immersive condition

Driving course with obstacles with a virtual reality headset

Immersive condition

Driving course with obstacles on a screen with physical simulator

Non Immersive condition

Driving course with obstacles on a screen only

Non Immersive condition

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female, over 18 years of age,
  • Patient with neurological disorders such as brain injury or neurodegeneration,
  • Having been prescribed an electric wheelchair and circulating in electric wheelchair for more than 3 months
  • Of which electric wheelchair is the main mode of travel
  • Whose physical measurements (weight, height) are compatible with the use of the physical simulator chosen for the development of the robotic assistance module, i.e. according to the manufacturer's data 140 kg max and 51 cm max seat width.
  • Having freely consented to participate in the study,
  • In the case of curatorship, having read the patient information document and given his/her free and informed consent to participate in the study, in the presence of his/her curator,
  • In the case of a guardianship, the legal representative having read the information document intended for the legal guardian of an adult under legal protection (under guardianship) and given his or her free and informed consent for the person for whom he or she is responsible to participate in the study (in agreement with the patient)

You may not qualify if:

  • Comprehension problems that prevent the protocol from being carried out,
  • Motor disorders of the upper limb requiring additional technical driving assistance,
  • A patient who has expressed difficulties with internal and/or external driving safety on the basis of the WST,
  • Patients who were included in the SIMADAPT1 study to avoid bias due to their experience in the simulator and virtual reality,
  • Pregnant, parturient or breastfeeding women,
  • Person deprived of liberty by a judicial or administrative decision, persons under psychiatric care or for purposes other than research,
  • Minor,
  • Person in emergency situation unable to give prior consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pole Saint-Hélier

Rennes, Brittany Region, 35000, France

Location

MeSH Terms

Conditions

Nervous System DiseasesBrain InjuriesNerve Degeneration

Interventions

Early Detection of Cancer

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Early DiagnosisDiagnosis

Study Officials

  • Philippe GALLIEN

    Pôle Saint Hélier

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: This is a pilot, prospective, single-centre, controlled, randomised, crossover, open-label, study. (RIPH2)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 3, 2021

First Posted

May 20, 2021

Study Start

May 10, 2021

Primary Completion

October 26, 2021

Study Completion

October 26, 2021

Last Updated

November 1, 2021

Record last verified: 2021-05

Locations